Scientific publications

BMC Medicine, 2026

CardioMetAge estimates cardiometabolic aging and predicts disease outcomes

Li Y., Xu X., Zheng Y. et al.

Journal of Neurosurgery: Pediatrics, 2026

Cell division cycle 42 binding protein beta as a plasma-based biomarker for cerebral cavernous malformations

Hattar Y., Sesen J., Martinez T. et al.

iScience, 2026

Persistent viral control status is associated with enhanced innate immune responses in people with HIV-1

C. dos Santos J., Groenendijk A., Ruijten S. et al.

International Journal of Biological Macromolecules, 2026

A role of FURIN in promoting TGF-β signaling activation in MAFLD: Evidence from UK Biobank proteomic cohort

Wang H., Li X., Xu X. et al.

Journal of Translational Medicine, 2026

Machine learning-based clinical prediction model and multi-omics integration for assessing pancreatic cancer risk in new-onset diabetes

Yang J., Cao B., Yuemaierabola A. et al.

Journal for ImmunoTherapy of Cancer, 2026

Clinical and translational results from a phase 1 trial of gemcitabine/nab-paclitaxel with nivolumab/ipilimumab or hydroxychloroquine/ipilimumab in untreated metastatic pancreatic adenocarcinoma

O’Reilly E., Cabanski C., Lyman J. et al.

Hypertension, 2026

Galectin-1 Is a Marker but Not a Mediator of Heart Failure With Preserved Ejection Fraction

Wassenaar J., Smart C., Fehrenbach D. et al.

Diabetologia, 2026

Adrenaline is a prominent driver of inflammatory responses following hypoglycaemia

Mustafajev I., Hendriksz M., Stienstra R. et al.

Blood Immunology & Cellular Therapy, 2026

Identification of a plasma immune marker panel for early detection of acute graft-versus-host disease in children

Klein Lebbink W., de Koning C., Kunstek H. et al.

Reviews in Cardiovascular Medicine, 2026

Olink Proteomics in Heart Failure: A Comprehensive Review of Applications From Biomarker Discovery to Pathophysiological Insights and Clinical Implementation

Zheng Z., Gong Z., Gu J.

Resuscitation, 2026

Large-scale plasma proteomic analysis identifies pathophysiological mechanisms and predictive biomarkers for cardiac arrest

Wang N., Guo Y., Lu S. et al.

eJHaem, 2026

Systemic Immune Alterations in Paediatric Classical Hodgkin Lymphoma With CCL17 and MCP‐4 as Diagnostic and Predictive Biomarkers

Hedberg G., Chen Q., Lakshmikanth T. et al.

GeroScience, 2026

Liver-specific phenotypic aging, behavior and genetic risks, and long-term liver-related outcomes

Wu T., Guo C., Yuan H. et al.

Nature Medicine, 2026

Fecal microbiota transplantation plus immunotherapy in non-small cell lung cancer and melanoma: the phase 2 FMT-LUMINate trial

Duttagupta S., Messaoudene M., Hunter S. et al.

Preventive Medicine Reports, 2026

Matrix metalloproteinases and risk of cardiovascular mortality and morbidity in the United Kingdom: A prospective cohort study with machine learning analysis

Huang J., Jiang H., Lu Y. et al.

RMD Open, 2026

Transcriptomic and proteomic analysis stratifies patients with axial spondyloarthritis based on disease activity, structural damage and radiographic progression

Cuesta-López L., Arias-de la Rosa I., Pérez-Sánchez C. et al.

Multiple Sclerosis Journal – Experimental, Translational and Clinical, 2026

Apolipoprotein E4 and its later-life health effects on the multiple sclerosis population

Zeldich D., Cheng C., Guan Y. et al.

Diabetology & Metabolic Syndrome, 2026

The role of hepatocyte growth factor in the relationship between body fat distribution and plasma markers of glucose metabolism: a cross-sectional study

Zakic K., Freuer D., Linseisen J. et al.

Nature Communications, 2026

Oligoprotein type I interferon signatures, but not TREX1 variants, increase risk of systemic lupus erythematosus in UK Biobank

Rioux B., McGlasson S., Forbes D. et al.

International Journal of Molecular Sciences, 2026

Serum Calprotectin in Hospitalized Patients with COVID-19 in Relation to High-Dimensional Serum Proteomic Patterns

Parke ?., Strunz B., Chen P. et al.